their fantastic work on Germline mutations in a G protein identify signaling cross-talk in T cells Victoria Saca , Colin Burdette , and Thomas Sakmar for their excellent study on GPCR Biosensors to Study Conformational

However, the effect of CCR9 on salivary adenoid cystic carcinoma (SACC) malignant behavior remains unknown investigate the specific molecular mechanism by which CCR9/CCL25 modulates malignant progression in SACC performed to detect the correlation of CCR9 expression and tumor progression-associated markers in SACC In vitro , SACC cell proliferation and apoptosis were evaluated using Cell Counting Kit-8 and colon formation The effect of CCL25 on the development of SACC in vivo was examined by a xenograft tumor model in nude

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Domain Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs

Technologies and Focus Clinical Development Expertise in Oncology Octant Bio will be at the Goldman Sachs